Preventing Disengagement in Coordinated Specialty Care for First Episode Psychosis Using Telemedicine and Smartphone Support

What this Trial Is About

Researchers are studying patients experiencing their first episode of psychosis who are receiving coordinated specialty care CSC. The study aims to identify those at high risk of disengaging from treatment and to test ways to prevent or delay this from happening. Maintaining engagement is important for patients to benefit fully from CSC, and this research focuses on improving that outcome. The study has two phases. In Phase 1, researchers will confirm a model that predicts which patients might later disengage from care. In Phase 2, participants identified as high risk will be randomly assigned to receive either a special Step-down intervention using web-based telemedicine and a smartphone app or the usual care provided by the CSC center. This intervention is designed to reduce the chance of disengagement. Participants will be monitored to see how often they stay engaged in care over at least six months. Researchers will measure the rate of disengagement between the two groups. The study will include assessments through telemedicine and app use, with ongoing follow-up to evaluate the effectiveness of the intervention in keeping patients connected with their care team. The total participation duration varies based on individual involvement in the study phases.

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs